The Claim
Sulforaphane supplementation at 120 μmol/day for 12 months does not significantly alter Caspase-3 or TUNEL apoptotic marker levels in bronchial tissue of former smokers.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 120 micromoles of sulforaphane daily for a year does not change levels of Caspase-3 or TUNEL markers in the bronchial tissue of former smokers.
See the scientific wording
Sulforaphane supplementation at 120 μmol/day for 12 months had no significant effect on Caspase-3 or TUNEL apoptotic markers in bronchial tissue of former smokers, indicating that its anti-proliferative effect is not mediated through increased apoptosis in this context.
Sulforaphane enters lung cells and turns on a protective system that cleans up harmful chemicals from smoking. This reduces damage to DNA, which stops the cells from dividing too fast. The cells do not die off more than usual; they just stop multiplying.
What the research says
1 studySulforaphane helped slow down abnormal cell growth in the lungs of former smokers, but it didn’t make those bad cells die faster — which means it works by stopping them from multiplying, not by killing them off.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.